Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
NYSE MKT COMPOSITE
Chelsea Therapeutics International Ltd.
(NQ:
CHTP
)
1.880
USD
-0.010 (-0.53%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
1.880
Bid (Size)
1.880 (17900)
Ask (Size)
1.890 (1700)
Prev. Close
1.890
Today's Range
1.860 - 1.920
52wk Range
0.7000 - 2.318
Shares Outstanding
67,085,154
Dividend Yield
N/A
Top News
More News
Today’s Research on HSP, ALKS, CLSN, THRX, and CHTP
May 13, 2013
from
ACCESSWIRE
Chelsea Therapeutics trims loss in 1Q
May 02, 2013
Chelsea Therapeutics International Ltd. reports a loss of $3.9 million, or 6 cents per share, for the first quarter. That improves on its loss of $15.6 million, or 23 cents per-share, in 2012’s first...
Read More
from
National Business News - Local Business News | bizjournals
More News
Read More
Chelsea Therapeutics International Ltd. (CHTP) Posts Q1 Loss of 6c/Share
May 01, 2013
from
StreetInsider.com News Articles
Chelsea Therapeutics Reports First Quarter 2013 Financial Results
May 01, 2013
from
GlobeNewswire News Releases
Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference
April 24, 2013
from
GlobeNewswire News Releases
Lead Counsel in Securities Class Action Against Chelsea Therapeutics International Ltd. Announces Court Hearing
April 19, 2013
from
PR Newswire
Pre-Market Analysis on Sarepta Therapeutics, BioMarin Pharma, Theravance, and Chelsea Therapeutics
April 08, 2013
from
PR Newswire
Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report
March 28, 2013
from
Marketwired News Releases
Stocks Showing Gaining Momentum: (NASDAQ:RVLT), (NASDAQ:CHTP)
March 28, 2013
from
SBWire Direct - Latest Press Releases
Chelsea Therapeutics' Northera Expected To Be Approved
March 27, 2013
from
MarketMinute.com Stock News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here